Funder
Fundação para a Ciência e a Tecnologia
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health,Health (social science)
Reference65 articles.
1. European Medicines Agency (2017). Guideline on Good Pharmacovigilance Practices (GVP): Annex I - Definitions. Available on: https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-good-pharmacovigilance-practices-annex-i-definitions-rev-4_en.pdf.
2. Matos, C., Rodrigues, L., & Joaquim, J. (2017). Attitudes and opinions of Portuguese community pharmacy professionals towards patient reporting of adverse drug reactions and the pharmacovigilance system. Drugs & Therapy Perspectives, 33(4), 188.
3. dos Santos Pernas, S. I., Herdeiro, M. T., Lopez-Gonzalez, E., da Cruz e Silva, O. A. B., & Figueiras, A. (2012). Attitudes of Portuguese health professionals toward adverse drug reaction reporting. International Journal of Clinical Pharmacy, 34(5), 693–698. https://doi.org/10.1007/s11096-012-9675-6
4. Herdeiro, M. T., Figueiras, A., Polonia, J., & Gestal-Otero, J. J. (2006). Influence of pharmacists’ attitudes on adverse drug reaction reporting : A case-control study in Portugal. Drug Safety, 29(4), 331–340. https://doi.org/10.2165/00002018-200629040-00004
5. Lopez-Gonzalez, E., Herdeiro, M. T., & Figueiras, A. (2009). Determinants of under-reporting of adverse drug reactions. Drug Safety, 32(1), 19–31. https://doi.org/10.2165/00002018-200932010-00002